Company Filing History:

16 out of 1,451

Sanofi

Years Active: 1993-2013

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8362067 - 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof (2013-01-29),

2. 8324214 - [object Object] (2012-12-04),

3. 6090818 - Indolin-2-one derivatives, method for preparing them and pharmaceutical (2000-07-18),

4. 6057318 - Heterocyclic derivatives, process for their preparation and their (2000-05-02),

5. 6046341 - 3-spiro-indolin-2-one derivatives (2000-04-04),

6. 5994350 - 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin (1999-11-30),

7. 5891894 - Heterocyclic derivatives process for their preparation and their (1999-04-06),

8. 5891893 - Heterocyclic derivatives, process for their preparation and their (1999-04-06),

9. 5849780 - 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their (1998-12-15),

10. 5780468 - Heterocyclic derivatives, process for their preparation and their (1998-07-14),

11. 5728723 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation (1998-03-17),

12. 5726322 - 1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives, their preparation (1998-03-10),

13. 5714497 - Compounds bearing sulphamoyl and amidino radicals, their preparation (1998-02-03),

14. 5696145 - 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the (1997-12-09),

15. 5686624 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation (1997-11-11),

Title: Innovations and Contributions of Gerard Valette in Pharmaceutical Patents

Introduction

Gerard Valette, an accomplished inventor based in Lacroix Falgarde, France, has made significant contributions to the field of pharmaceuticals with his innovative inventions. With a portfolio of 21 patents, he has focused his research on the development of novel therapeutic compounds.

Latest Patents

Among his latest patents is the invention of 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, which details their preparation and therapeutic applications. These compounds exhibit a strong affinity and high selectivity for human arginine-vasopressin (AVP) Vreceptors. The inventive compounds align with the following formula (I), where the variables are defined as stated in the specification, showcasing their potential for targeted therapeutic use.

Career Highlights

Gerard Valette has had a distinguished career, with significant tenures at renowned pharmaceutical companies such as Sanofi and Sanofi-Synthelabo. His work has been pivotal in advancing drug development and therapeutic options in the medical field.

Collaborations

Throughout his career, Gerard has collaborated with industry professionals such as Loic Foulon and Georges Garcia, further enhancing innovation and expertise within his projects. These collaborations have fostered an environment of creativity, leading to the attainment of numerous patents and advancements in pharmacology.

Conclusion

Gerard Valette's innovative spirit and expertise in pharmaceuticals have resulted in groundbreaking patents that contribute to therapeutic advancements. His commitment to research and collaboration highlights the importance of inventors in driving progress within the medical community. As an esteemed inventor, Valette continues to influence the field with his substantial contributions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.